Problem statement: Answer the multiple-choice question.
Question: Which compound exhibits a 22.631\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a) CCCCN1C(N)=NC[C@@H]1CC1CCCCC1
b) CN(C(=O)CN1C(=O)/C(=C/c2ccccc2F)SC1=S)C1CCS(=O)(=O)C1
Answer: b. CN(C(=O)CN1C(=O)/C(=C/c2ccccc2F)SC1=S)C1CCS(=O)(=O)C1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN(C(=O)CN1C(=O)/C(=C/c2ccccc2F)SC1=S)C1CCS(=O)(=O)C1
CN(C(=O)CN1C(=O)/C(=C/c2ccccc2F)SC1=S)C1CCS(=O)(=O)C1
N-(1,1-dioxothiolan-3-yl)-2-[(5Z)-5-[(2-fluorophenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]-N-methylacetamide